Your browser doesn't support javascript.
loading
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial.
Maher, Toby M; Tudor, Veronica A; Saunders, Peter; Gibbons, Michael A; Fletcher, Sophie V; Denton, Christopher P; Hoyles, Rachel K; Parfrey, Helen; Renzoni, Elisabetta A; Kokosi, Maria; Wells, Athol U; Ashby, Deborah; Szigeti, Matyas; Molyneaux, Philip L.
Afiliação
  • Maher TM; Division of Pulmonary, Critical Care, and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Guy's and St Thomas' NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: toby.maher@me
  • Tudor VA; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Saunders P; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK.
  • Gibbons MA; Academic Department of Respiratory Medicine, Royal Devon & Exeter Foundation NHS Trust, Exeter, UK; College of Medicine & Health, University of Exeter, UK.
  • Fletcher SV; NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
  • Denton CP; Centre for Rheumatology, Division of Medicine, Royal Free Campus, University College London, London, UK.
  • Hoyles RK; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK.
  • Parfrey H; Interstitial Lung Disease Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
  • Renzoni EA; Guy's and St Thomas' NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Kokosi M; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Wells AU; Guy's and St Thomas' NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
  • Ashby D; School of Public Health, Imperial College London, London, UK.
  • Szigeti M; Imperial Clinical Trials Unit, Imperial College London, London, UK; Physiological Controls Research Center, Obuda University, Budapest, Hungary.
  • Molyneaux PL; Guy's and St Thomas' NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
Lancet Respir Med ; 11(1): 45-54, 2023 01.
Article em En | MEDLINE | ID: mdl-36375479
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Doenças do Tecido Conjuntivo Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Respir Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Doenças do Tecido Conjuntivo Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Respir Med Ano de publicação: 2023 Tipo de documento: Article